Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-03-22 | Phathom Pharmaceuticals, Inc. | Curran Terrie
(President and Chief Executive) |
S | Common Stock | D | 16851 | $9.11 - $9.11 | $153,512 |
| 2024-01-24 | Phathom Pharmaceuticals, Inc. | TAKEDA PHARMACEUT...
(AtLeastTenPercentOwner) |
S | Common Stock | D | 3703703 | $8.10 - $8.10 | $29,999,994 |
| 2024-01-19 | Phathom Pharmaceuticals, Inc. | Henderson Molly
(CFO and CBO) |
S | Common Stock | D | 6307 | $7.75 - $7.75 | $48,900 |
| 2023-11-06 | Phathom Pharmaceuticals, Inc. | Parikh Asit
(Director) |
P | Common Stock | A | 7500 | $7.76 - $8.04 | $58,579 |
| 2023-11-01 | Phathom Pharmaceuticals, Inc. | Henderson Molly
(CFO and CBO) |
S | Common Stock | D | 12492 | $7.80 - $8.95 | $110,869 |
| 2023-11-01 | Phathom Pharmaceuticals, Inc. | Henderson Molly
(CFO and CBO) |
A | Common Stock | A | 22500 | $0.00 - $0.00 | $0 |
| 2023-11-01 | Phathom Pharmaceuticals, Inc. | Nabulsi Azmi
(Chief Operating Officer) |
A | Common Stock | A | 32500 | $0.00 - $0.00 | $0 |
| 2023-11-01 | Phathom Pharmaceuticals, Inc. | Curran Terrie
(President and Chief Executive) |
A | Common Stock | A | 37500 | $0.00 - $0.00 | $0 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |